TMCnet News

Research and Markets: Global Pharma Rising Stars Outlook 2015
[March 05, 2015]

Research and Markets: Global Pharma Rising Stars Outlook 2015


Research and Markets (http://www.researchandmarkets.com/research/f3c54b/global_rising) has announced the addition of the "Global Rising Stars Outlook 2015" report to their offering.

Innovative Therapies for treating diseases are being sought after with fresh vigor as new targets , approaches and biology is discovered. One field which is poised to bring a paradigm change in the way diseases are treated in the next decades is the Stem cell therapy/Regenerative Medicine space.

The number of companies and products in the clinic have reached a critical mass warranting a close watch for those interested in keeping pace with the development of new medicines. The Regenerative medicine Universe is large and new companies are being added to it rapidly. As a result we have used some filters to select a few names for a detailed coverage in our Outlook this year.

Key Criteria for Our Selection are:

- Uniqueness of the technology platform and the ability to scale up commercially in case of positive outcomes of products in the pipeline

Pipeline and clinical data analysis



- Marketed product and commercial tie up, robustness of the management, financial and business model

Key Topics Covered:


Part 1- Rising Stars in Regenerative Medicine and Stem cell based Cell Therapies-Drugs of the Future

  • CESCA Therapeutics Inc.: Hedging the Risk with Stem Cell Based Devices and Therapies and Global Presence
  • Ocata Therapeutics Inc.: Ophthalmic Focus- Macular degenerative conditions- Looking with a New Eye
  • Orgenesis: Focus- Diabetes- Tricking your Liver to Make Insulin!
  • Tigenix NV: Exploiting the Adipose Tissue- Multiple Applications of Fat?
  • Pluristem Therapeutics Inc.: Regenerating and Recycling- Allogenic Therapies from the Placenta
  • Mesoblast: Leader in Regenerative Space in Korea- Focusing on International Markets
  • Medipost Co Ltd.: Leader in Regenerative Space in Korea- Focusing on International Markets
  • JCR Pharmaceuticals co. Ltd.: First Stem Cell Based Product in Japan for Graft-Versus-Host Disease (GVHD).
  • Japan Tissue Engineering co. Ltd.: Building Confidence in Regenerative Medicine- Fuji film Venture from Colors to Regenerative Medicine

Part II-Indian Innovators- Rising Stars:

  • Connexios: Maturing Pipeline and Focus on Diabetes/Metabolic Disorders to Drive Visibility
  • Cellworks: In silico Technology Platform Poised to Deliver- Focus on Personalised Medicine and Cancer
  • Bugworks: In silico Technology platform being applied to Serious Hospital Infections- Need of the hour!
  • Tergene: Affordable and Second Generation Vaccines- Addressing the Urgent needs of Emerging Markets.

Companies Mentioned

- Bugworks

- CESCA Therapeutics

- Cellworks

- Connexios

- JCR Pharmaceuticals

- Japan Tissue Engineering

- Medipost

- Mesobalst

- Mesobalst Ltd

- OCATA Therapeutics

- Orgenesis

- Pluristem Therapeutics

- Tergene

- TiGenix

For more information visit http://www.researchandmarkets.com/research/f3c54b/global_rising.


[ Back To TMCnet.com's Homepage ]